Strategies for Removing Endocrine Disrupting Chemicals (EDCs) from Wastewater

IF 2.2 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Current pharmaceutical biotechnology Pub Date : 2024-09-10 DOI:10.2174/0113892010317251240826051110
Sayanee Sarkar, Ayesha Zafar, Sourav Paul, Bishal Das, Deepika Biswas, Jigisha Roy Panda
{"title":"Strategies for Removing Endocrine Disrupting Chemicals (EDCs) from Wastewater","authors":"Sayanee Sarkar, Ayesha Zafar, Sourav Paul, Bishal Das, Deepika Biswas, Jigisha Roy Panda","doi":"10.2174/0113892010317251240826051110","DOIUrl":null,"url":null,"abstract":"Introduction: Endocrine-disrupting drugs, also called endocrine disruptors or micropollutants, cause serious environmental and public health problems due to their ability to disrupt the endocrine functions of organisms and humans, even at low concentrations. This report provides a summary of current removal techniques, such as activated sludge processes, membrane filtration, adsorption, and membrane bioreactor techniques for endocrine-disrupting chemicals, including their efficiency, limitations, and practical implementation. Methods: This review evaluates these methods by considering their treatment efficiency, costs, and environmental impact. To curb this menace, several developed countries have distinct strategies, such as physical remediation techniques, biological processes, phytoremediation, and chemical processes to remove endocrine disruptors. Results: In developing nations, most conventional wastewater treatment plants do not even monitor those contaminants due to the low biodegradability and high complexity of such compounds. Conclusion: Hence, in this review work, potential endocrine-disrupting chemicals, their impacts, mechanisms of action, consequences for human health, and bio-mitigation strategies reported so far have been discussed in the context of the relevant literature.","PeriodicalId":10881,"journal":{"name":"Current pharmaceutical biotechnology","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113892010317251240826051110","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Endocrine-disrupting drugs, also called endocrine disruptors or micropollutants, cause serious environmental and public health problems due to their ability to disrupt the endocrine functions of organisms and humans, even at low concentrations. This report provides a summary of current removal techniques, such as activated sludge processes, membrane filtration, adsorption, and membrane bioreactor techniques for endocrine-disrupting chemicals, including their efficiency, limitations, and practical implementation. Methods: This review evaluates these methods by considering their treatment efficiency, costs, and environmental impact. To curb this menace, several developed countries have distinct strategies, such as physical remediation techniques, biological processes, phytoremediation, and chemical processes to remove endocrine disruptors. Results: In developing nations, most conventional wastewater treatment plants do not even monitor those contaminants due to the low biodegradability and high complexity of such compounds. Conclusion: Hence, in this review work, potential endocrine-disrupting chemicals, their impacts, mechanisms of action, consequences for human health, and bio-mitigation strategies reported so far have been discussed in the context of the relevant literature.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
去除废水中干扰内分泌的化学品 (EDC) 的策略
导言:干扰内分泌的药物,又称内分泌干扰物或微污染物,由于能够干扰生物体和人类的内分泌功能,即使浓度很低,也会造成严重的环境和公共健康问题。本报告概述了目前针对干扰内分泌的化学品的去除技术,如活性污泥法、膜过滤、吸附和膜生物反应器技术,包括其效率、局限性和实际应用。方法:本综述从处理效率、成本和环境影响等方面对这些方法进行了评估。为了遏制这一威胁,一些发达国家采取了不同的策略,如物理修复技术、生物工艺、植物修复和化学工艺来清除内分泌干扰物。结果:在发展中国家,由于这类化合物的生物降解性低、复杂性高,大多数传统废水处理厂甚至不监测这些污染物。结论因此,本综述结合相关文献,讨论了迄今为止报道的潜在内分泌干扰化学品、其影响、作用机制、对人类健康的后果以及生物缓解策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current pharmaceutical biotechnology
Current pharmaceutical biotechnology 医学-生化与分子生物学
CiteScore
5.60
自引率
3.60%
发文量
203
审稿时长
6 months
期刊介绍: Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include: DNA/protein engineering and processing Synthetic biotechnology Omics (genomics, proteomics, metabolomics and systems biology) Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes) Drug delivery and targeting Nanobiotechnology Molecular pharmaceutics and molecular pharmacology Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes) Pharmacokinetics and pharmacodynamics Applied Microbiology Bioinformatics (computational biopharmaceutics and modeling) Environmental biotechnology Regenerative medicine (stem cells, tissue engineering and biomaterials) Translational immunology (cell therapies, antibody engineering, xenotransplantation) Industrial bioprocesses for drug production and development Biosafety Biotech ethics Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
期刊最新文献
Dihydroartemisinin Modulates Prostate Cancer Progression by Regulating Multiple Genes via the Transcription Factor NR2F2. Extraction, Isolation, Characterization, and Development of Phospholipids Complex Nanocarrier for Improved Solubility, Antiasthmatic, and Pharmacokinetic Potential of Curcuminoids. A Liquid Band-Aid with Mesenchymal Stem Cell-Derived Exosomes for Wound Healing in Mice. Ampullaviruses: From Extreme Environments to Biotechnological Innovation. Biomarkers and Novel Therapies of Diabetic Neuropathy: An Updated Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1